OTC Supplements for the Management of High Cholesterol

摘要

Cardiovascular disease remains the leading cause of mortality and morbidity in the United States, with coronary artery disease (CAD) being the number-one cause of death. Dyslipidemia is a major contributor to the development of CAD and other forms of atherosclerosis; individuals with high total cholesterol levels (≥240 mg/dL) have about twice the risk for heart disease. Approximately 100 million adults in the U.S. have total cholesterol levels >200 mg/dL (borderline high), and almost 74 million have high levels of low-density lipoprotein cholesterol (LDL-C). Adults aged >20 years should have their cholesterol measured at least once every 5 years.